Advertisement
UK markets close in 9 minutes

  • FTSE 100

    8,139.67
    +60.81 (+0.75%)
     

  • FTSE 250

    19,828.36
    +226.38 (+1.15%)
     

  • AIM

    755.01
    +1.89 (+0.25%)
     

  • GBP/EUR

    1.1662
    +0.0005 (+0.04%)
     

  • GBP/USD

    1.2452
    -0.0059 (-0.47%)
     

  • Bitcoin GBP

    51,174.39
    +165.05 (+0.32%)
     

  • CMC Crypto 200

    1,329.89
    -66.65 (-4.77%)
     

  • S&P 500

    5,095.61
    +47.19 (+0.93%)
     

  • DOW

    38,152.50
    +66.70 (+0.18%)
     

  • CRUDE OIL

    83.61
    +0.04 (+0.05%)
     

  • GOLD FUTURES

    2,345.30
    +2.80 (+0.12%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     

  • DAX

    18,161.21
    +243.93 (+1.36%)
     

  • CAC 40

    8,095.42
    +78.77 (+0.98%)
     
PROPERTY:

9 luxury homes to consider if money is no object

Ever thought about what a multimillion pound budget would buy you?

Hofseth Biocare ASA: PRIMARY INSIDER NOTIFICATION

Hofseth Biocare ASA

Christoph Baldegger, primary insider and member of the Board of Directors in Hofseth BioCare ASA («HBC») has today purchased 50,000 shares in HBC at an average price of NOK 7.7295 per share.

As a result of the transaction, Mr. Baldegger holds 700,000 shares in HBC, equal to approx. 0.20 % of the outstanding shares.

This information is subject of the disclosure requirements pursuant to sections 4-2 and 5-12 of the Norwegian Securities Trading Act.